19-3976443-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001961.4(EEF2):c.*111C>T variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.0202 in 1,289,062 control chromosomes in the GnomAD database, including 3,991 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.097 ( 2403 hom., cov: 33)
Exomes 𝑓: 0.0099 ( 1588 hom. )
Consequence
EEF2
NM_001961.4 3_prime_UTR
NM_001961.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.18
Genes affected
EEF2 (HGNC:3214): (eukaryotic translation elongation factor 2) This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 19-3976443-G-A is Benign according to our data. Variant chr19-3976443-G-A is described in ClinVar as [Benign]. Clinvar id is 1280735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EEF2 | NM_001961.4 | c.*111C>T | 3_prime_UTR_variant | 15/15 | ENST00000309311.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EEF2 | ENST00000309311.7 | c.*111C>T | 3_prime_UTR_variant | 15/15 | 5 | NM_001961.4 | P1 | ||
EEF2 | ENST00000600794.1 | c.108-143C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0972 AC: 14777AN: 152086Hom.: 2397 Cov.: 33
GnomAD3 genomes
AF:
AC:
14777
AN:
152086
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00985 AC: 11201AN: 1136858Hom.: 1588 Cov.: 16 AF XY: 0.00846 AC XY: 4792AN XY: 566138
GnomAD4 exome
AF:
AC:
11201
AN:
1136858
Hom.:
Cov.:
16
AF XY:
AC XY:
4792
AN XY:
566138
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0973 AC: 14813AN: 152204Hom.: 2403 Cov.: 33 AF XY: 0.0940 AC XY: 6995AN XY: 74432
GnomAD4 genome
AF:
AC:
14813
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
6995
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 11, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at